Preserve Clinical Trial Integrity

Patient Behavioural Risk: Nonadherence or early drop-out

Patient trust in the trial or the medication can affect recruitment and result in either nonadherence or early drop-out causing potential delay to clinical trial completion and reduced data quality. These impacts can have a significant knock-on effect on overall costs, launch success and sales revenue.

Personia Solutions

We help you detect behavioural risk early, enabling Clinical Researchers to reliably predict which patients are at risk of nonadherence. Our tools categorise patients by level of risk, helping you understand why a patient is at risk and inform the development of evidence-based mitigating interventions.

Recruitment, trial enhancement and intervention

TARA™ (Treatment Activation and Adherence Risk Assessment)

TARA-Screen™
Helps you assess risk during recruitment and throughout the trial.
TARA-Assess™
Provides insight into the underlying causes of behavioural risk in each patient.
TARA-Activate™
Suggests personalised, evidence-based interventions that keep patients engaged and the trial on track.

Request a demo of TARA

Measurement

MARS™ (The Medication Adherence Report Scale)
Recognised as a reliable self-reporting measure of nonadherence in clinical trial and patient registry settings.
BMQ™ (Beliefs About Medicines Questionnaire)
Provides you with insight into the patient’s beliefs about medicines that influence treatment engagement.

Preserve Clinical Trial Integrity

Patient Behavioural Risk: Nonadherence or early drop-out

Personia Solutions

Recruitment, trial enhancement and intervention

Measurement

Case Study

Would you like to find out more about how we can help you improve clinical trial design, commercial success or patient engagement?